News on AstraZeneca
There has been 186 news on AstraZeneca in the past from 34 sources across 5 sections.
Access to all news on this scope:
See the trend on this scope:
Evolution through time
Sentiment analysis
Current sentiment polarity: neutral with a score of 0
Sentiment polarity through time
Latest news
Signs of relief for AstraZeneca as China courts foreign investors
AstraZeneca hit with US class action lawsuit over China regulatory probes
Inside AstraZeneca's abandoned UK vaccine plant deal as Labour and Tories face questions over PS450m collapse
The inside story of Britain's failure to clinch PS450mn AstraZeneca deal
Failed AstraZeneca deal is no way to sell Labour's pro-growth ambitions
AstraZeneca sales jump despite troubles in China
AstraZeneca ditches plan to build PS450mn UK vaccine plant
Blow for Reeves as AstraZeneca ditches PS450m investment
Government hits back in AstraZeneca funding row
Tory slams Labour's collapse of PS450m AstraZeneca deal as 'terrible failure'
AstraZeneca investment deal 'didn't add up for UK taxpayer', says minister
AstraZeneca rejected close to PS80mn in state support for cancelled Speke factory
AstraZeneca scraps £450m vaccine plant after Labour funding cut
AstraZeneca move leaves Reeves under the weather
Fresh blow for Rachel Reeves as AstraZeneca scraps PS450m investment in UK vaccine plant
Rachel Reeves accused of 'fumbling' AstraZeneca's PS450m vaccine plant plans
Covid-19 vaccines: Doctor's role in identifying AstraZeneca's concerning side effects
AstraZeneca overhauls management of its scandal-hit China division
AstraZeneca insiders expect sales dip in China after arrest of local boss
AstraZeneca appoints new China head after long-standing executive detained
Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy
Healthy Returns: Weight loss drug race heats up with pill data from Viking Therapeutics, AstraZeneca
China has trapped the tiger of AstraZeneca's growth
AstraZeneca embarks on major US expansion
Sections
The coverage spans across 5 sections:
Sources
There has been 34 news sources reporting on this, including: Financial Times (22%), Times of India (11%), The Wall Street Journal (10%), CNBC News (8%), and Bloomberg (6%).
Going further
Stay up to date:
Details
This content is available under the CC BY 4.0 license.